Skip to main content
. 2024 Jun 21;3(7):1012–1019. doi: 10.1016/j.gastha.2024.06.003

Table 2.

Trials Adherence to the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) Statement

SPIRIT domain Bretthauer 2022 (NordICC) Atkin 2017 (UKFSST) Holmes 2014 (NORCCAP) Schoen 2012 (PLCO) Segnan 2011 (SCORE) Total %
Administrative information: (total 9), n (%) 6 (66.7%) 8 (88.9%) 8 (88.9%) 7 (77.8%) 7 (77.8%) 80%
Introduction: (total 4), n (%) 4 (100%) 4 (100%) 4 (100%) 4 (100%) 4 (100%) 100%
Methods:participants, interventions, and outcomes: (total 10), n (%) 10 (100%) 10 (100%) 10 (100%) 9 (90%) 10 (100%) 98%
Methods: Assignment of interventions: (total 5), n (%) 3 (60%) 4 (80%) 3 (60%) 5 (100%) 4 (80%) 76%
Methods: Data collection, management, and analysis: (total 6), n (%) 6 (100%) 6 (100%) 4 (67%) 6 (100%) 6 (100%) 93.3%
Methods: Monitoring: (total 4), n (%) 4 (100%) 2 (50%) 2 (50%) 4 (100%) 3 (75%) 75%
Ethics and dissemination: (total 11), n (%) 9 (81.8%) 8 (72.7%) 10 (90.9%) 11 (100%) 11 (100%) 89.1%
Appendices: (total 2), n (%) 1 (50%) 1 (50%) 1 (50%) 1 (50%) 1 (50%) 60%
Total (51) 43 (84.3%) 43 (84.3%) 42 (82.4%) 47 (92.2%) 46 (90.2%) (86.6%)

NORCCAP, Norwegian Colorectal Cancer Prevention; NordICC,Nordic-European Initiative on Colorectal Cancer; PLCO, Prostate, Lung, Colorectal, and Ovarian; SCORE, Screening for Colorectal; SPIRIT, Standard Protocol Items: Recommendations for Interventional Trials; UKFSST, United Kingdom Flexible Sigmoidoscopy Screening Trial.